Skip to main content
OpenTrials

Clinical trial condition

Connective Tissue Diseases

Explore clinical trials studying Connective Tissue Diseases. Study availability and eligibility vary by location and protocol.

5,710 public trials 870 recruiting studies
Refine in advanced search Browse all conditions

Connective Tissue Diseases trial results

Recruiting

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

NCT06154252

Conditions
Anti-synthetase Syndrome, Autoimmune Diseases, Connective Tissue Diseases, +16 more
Locations
  • University of California Irvine - Accepting Adult Patients Orange, California, United States
  • University of California, San Francisco Benioff Children's Hospital - Accepting Young Adult and Juvenile Patients San Francisco, California, United States
  • Children's Hospital Colorado - Accepting Juvenile Patients Aurora, Colorado, United States
  • Mayo Clinic Florida - Accepting Adult Patients Jacksonville, Florida, United States
View all 35 locations
View Trial Details
Recruiting

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

NCT06371417

Conditions
Antiphospholipid Syndrome, Antiphospholipid Syndrome (APS), Autoimmune Diseases, +50 more
Locations
  • University of California-Irvine Orange, California, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Northwell Health, LLC PRIME Lake Success, New York, United States
  • Hospital for Special Surgery New York, United States
View all 77 locations
View Trial Details
Recruiting

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

NCT06925542

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Diffuse Cutaneous Systemic Sclerosis, +23 more
Locations
  • Stanford University Medical Center Redwood City, California, United States
  • Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States
  • University of Iowa Iowa City, Iowa, United States
  • Manning Family Children's Hospital of New Orleans New Orleans, Louisiana, United States
View all 14 locations
View Trial Details
Recruiting

Achievement of LLDAS5 in Patients With Systemic Lupus Erythematosus Treated With Anifrolumab.

NCT07330245

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +2 more
Locations
  • Azienda Ospedaliero-Universitaria di Cagliari Presidio di Monserrato Monserrato, CA, Italy
  • Azienda Ospedaliero-Universitaria di Ferrara Arcispedale Sant'Anna Cona, Ferrara, Italy
  • IRCCS Casa Sollievo della Sofferenza San Giovanni Rotondo, Foggia, Italy
  • IRCCS Humanitas Research Hospital Rozzano, Milano, Italy
View all 22 locations
View Trial Details
Recruiting

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

NCT06328777

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +6 more
Locations
  • Yale University New Haven, Connecticut, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • Northwestern Memorial Hospital Chicago, Illinois, United States
  • The University of Chicago Medical Center Chicago, Illinois, United States
View Trial Details
Recruiting

Childhood-onset Lupus Nephritis Initial Glucocorticoid-dose Harmonization Trial (LIGHT Trial)

NCT07719140

Conditions
Autoimmune Diseases, Childhood-onset Systemic Lupus Erythematosus, Connective Tissue Diseases, +13 more
Locations
  • Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Beijing Children's Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Chidren's Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
  • Shenzhen Children's Hospital Shenzhen, Guangdong, China
View Trial Details

Related conditions